Following the $CIENCE? (Bookmarks)
I have lots of things bookmarked that I’ll never get through, but back in 2021, I created the “Corrupt Scientific Medical Research” post, featuring videos of former editors and others, and included journal publications showing that Scientific Literature is mostly a Marketing Tool for Industry, and that most Journals themselves were “captured” by Industry (in that big industry pays their bills; they cannot “bite the hand that feeds them”), and that universities get their funding from grants — from the same industry. In other words, academia is captured and the “science” people trust with their lives; that your doctor or government is trusting, needs to be scrutinized as “$cience-fiction”. Head over to that post if you haven’t read it. It really is one of the reasons I woke up by going the “science” route at the start of this mess.
I went through and took screenshots of as many publications as I could, from the years 1992-2021. I even downloaded 41 of the publications and took screenshots, highlighted them all, and uploaded it to Mega and shared it to all my social media channels (hoping to get through to people before they held out their arms).
Anyway, I didn’t post everything that day, but have all these bookmarked saved to go through “one day”. I’m never going to get around to it, so I thought I’d at least post the links I had bookmarked here. You never know if a random post you make, might help someone snap out of the “Trust the $cience” hypnosis and save themselves or their loved ones from future humanity violations—such as climate-hysteria and “flu-scares”.
Some of the publications are editorial comments that propose solutions to the corruption:
- Focus on the Funding and Production of Evidence Rather Than Its Publication (01)
- Little Fish Are Less Likely to Take the Bait (02)
- Bitter Pills and Puffed Trials (03)
- Medical Journals, Academia, and Industry-Sponsored Clinical Trials (04)
- Conflict of interest in peer-reviewed medical journals: the world association of medical editors position on a challenging problem – PubMed (05)
- Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue – cohort study – PubMed (06)
- Medical journals and pharmaceutical companies: uneasy bedfellows – PubMed (07)
- Ethics in pharmaceutical advertising – PubMed (08)
- Psychology in the prescription era: building a firewall between marketing and science – PubMed (09)
- The need for “gentle medicine” in a post Covid-19 world – PubMed (10)
- Not the Last Word: Masks and the Veil of Ignorance – PubMed (11)
- Dishonesty and research misconduct within the medical profession – PubMed (12)
- Conflicts of interest in research on electronic cigarettes – PubMed (13)
- Accuracy of pharmaceutical advertisements in medical journals – PubMed (14)
- Pharmaceutical advertisements in leading medical journals: experts’ assessments – PubMed (15)
- Pharmaceutical industry sponsorship and research outcome and quality: systematic review – PubMed (16)
- Are randomised controlled trials in the BMJ different? – PubMed (17)
- HARLOT plc: an amalgamation of the world’s two oldest professions – PubMed (18)
- Redundancy, disaggregation, and the integrity of medical research – PubMed (19)
- High rate of inbreeding in Spanish universities – PubMed (20)
- How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data – PubMed (21)
- Repairing research integrity – PubMed (22)
- Suspected research fraud: difficulties of getting at the truth – PubMed (23)
- Investigating the previous studies of a fraudulent author – PubMed (24)
- Publish or perish-or both – PubMed (25)
- Role of editors and journals in detecting and preventing scientific misconduct: strengths, weaknesses, opportunities, and threats – PubMed (26)
- Academia and industry: increasingly uneasy bedfellows – PubMed (27)
- A review of conflict of interest, competing interest, and bias for toxicologists – PubMed (28)
- Déjà vu–a study of duplicate citations in Medline – PubMed (29)
- Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research – PubMed (30)
- Financial anatomy of biomedical research – PubMed (31)
- Making sense of non-financial competing interests – PubMed (32)
- Addressing conflict in strategic literature reviews: disclosure is not enough – PubMed (33)
- Press-released papers are more downloaded and cited – PubMed (34)
- How could disclosure of interests work better in medicine, epidemiology and public health: How do potential conflicts of interest confuse medicine and public health? – PubMed (35)
- Scientific misconduct: a new approach to prevention – PubMed (36)
- Uniform format for disclosure of competing interests in ICMJE Journals – PubMed (37)
- Reliability of disclosure forms of authors’ contributions – PubMed (38)
- Editors’ declaration of their own conflicts of interest – PubMed (39)
- Science journal editors’ views on publication ethics: results of an international survey – PubMed (40)
- Has the hunt for conflicts of interest gone too far? No (41)
- Physicians and the pharmaceutical industry: is a gift ever just a gift? – PubMed (42)
- Physicians’ behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary – PubMed (43)
- The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States (44)
- A national survey of physician-industry relationships – PubMed (45)
- Scope and impact of financial conflicts of interest in biomedical research: a systematic review – PubMed (46)
- Interactions between pharmaceutical representatives and doctors in training. A thematic review – PubMed (47)
- Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions – PubMed (48)
- All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving – PubMed (49)
- A social science perspective on gifts to physicians from industry – PubMed (50)
- Failing the public health–rofecoxib, Merck, and the FDA – PubMed (51)
- Defining financial conflicts and managing research relationships: an analysis of university conflict of interest committee decisions – PubMed (52)
- Reporting bias in medical research – a narrative review (53)
- Modified versus standard intention-to-treat reporting: Are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study (54)
- Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO (55)
- Integrity in Authorship and Publication (56)
- Extended report: Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice (57)
- Marketing, Media, Wishful Thinking, and Conflicts of Interest: Inflating the Value of New Medical Technology (58)
- Duplicate Publications in Korean Medical Journals Indexed in KoreaMed (59)
- Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than Others (60)
- “Good Publication Practice for Pharmaceutical Companies”: Where Are We Now? (61)
- Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications (62)
- Consensus and contention regarding redundant publications in clinical research: cross-sectional survey of editors and authors (63)
- Being a modern pharmaceutical company (64)
- Doubt is their product: how industry’s assault on science threatens your health (65)
- The truth about the drug companies: How they deceive us and what to do about it (66)
Site Notifications/Chat:
- Telegram Post Updates @JourneyToABetterLife (channel)
- Telegram Chatroom @JourneyBetterLifeCHAT (say hi / share info)
- Gettr Post Updates @chesaus (like fakebook)
Videos:
References